PEEKDIRECT Trademark

Trademark Overview

On Tuesday, May 26, 2026, a trademark application was filed for PEEKDIRECT with the United States Patent and Trademark Office. The USPTO has given the PEEKDIRECT trademark a serial number of 99846528. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 26, 2026. This trademark is owned by Peek Healthcare Technologies, Inc.. The PEEKDIRECT trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing patient populations with access to prescription medications at transparent, predictable point-of-sale pricing direct from manufacturers
peekdirect

General Information

Serial Number99846528
Word MarkPEEKDIRECT
Filing DateTuesday, May 26, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, May 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding patient populations with access to prescription medications at transparent, predictable point-of-sale pricing direct from manufacturers
Pseudo MarkPEEK DIRECT

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 26, 2026
Primary Code035
First Use Anywhere DateWednesday, October 8, 2025
First Use In Commerce DateWednesday, October 8, 2025

Trademark Owner History

Party NamePeek Healthcare Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalm Beach, FL 33418
US

Trademark Events

Event DateEvent Description
Tuesday, May 26, 2026NEW APPLICATION ENTERED
Tuesday, May 26, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

peekdirect sale point pricing direct manufacturers from predictable transparent populations patient